Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Construction In Progress : ¥1,042 Mil (As of Mar. 2024)

View and export this data going back to 2000. Start your Free Trial

What is Jiangsu Hengrui Pharmaceuticals Co Construction In Progress?

Jiangsu Hengrui Pharmaceuticals Co's quarterly construction in progress declined from Sep. 2023 (¥1,367 Mil) to Dec. 2023 (¥1,101 Mil) and declined from Dec. 2023 (¥1,101 Mil) to Mar. 2024 (¥1,042 Mil).

Jiangsu Hengrui Pharmaceuticals Co's annual construction in progress declined from Dec. 2021 (¥1,659 Mil) to Dec. 2022 (¥1,193 Mil) and declined from Dec. 2022 (¥1,193 Mil) to Dec. 2023 (¥1,101 Mil).

Jiangsu Hengrui Pharmaceuticals Co Construction In Progress Historical Data

The historical data trend for Jiangsu Hengrui Pharmaceuticals Co's Construction In Progress can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Jiangsu Hengrui Pharmaceuticals Co Construction In Progress Chart

Jiangsu Hengrui Pharmaceuticals Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Construction In Progress

Get a 7-Day Free Trial

1,532.83

1,305.07

1,659.02

1,193.20

1,101.00

Jiangsu Hengrui Pharmaceuticals Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Construction In Progress	Get a 7-Day Free Trial															1,219.91	1,290.13	1,366.78	1,101.00	1,041.71

Jiangsu Hengrui Pharmaceuticals Co Construction In Progress Calculation

It records the cost of construction work, which is not yet completed (typically, applied to capital budget items). A construction in progress item is not depreciated until the asset is placed in service. Normally, upon completion, a construction in progress item is reclassified, and the reclassified asset is capitalized and depreciated.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Jiangsu Hengrui Pharmaceuticals Co Ltd (SHSE:600276) » Definitions » Construction In Progress

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 38, Huanghe Road, Economic, Economic and Technological Development Zone, Jiangsu Province, Lianyugang, CHN, 222047

Website

http://www.hrs.com.cn

Jiangsu Hengrui Pharmaceuticals Co Ltd is engaged in the field of cancer treatment drugs, surgical medicines, endocrine therapy drugs, cardiovascular drugs and anti-infection medications. It specializes in the research and development of new medicines in areas of antineoplastics, endocrine system, cardiovascular, and the immune system.

Jiangsu Hengrui Pharmaceuticals Co (SHSE:600276) Headlines

No Headlines